Cervical cancer develops in the cervix (the lower part of the uterus) and is most commonly caused by persistent infection with the Human Papillomavirus (HPV).
Nearly 99% of cervical cancer cases are linked to persistent HPV infection
It often takes 8-10 years for precancerous cells to develop into cancer
Regular screening
Pain during intercourse or unexplained pelvic discomfort
Cervical cancer often shows no symptoms in its early stages. This is why regular screening is crucial for early detection. Don't wait for symptoms to appear
Understanding your risk factors helps you take proactive steps toward prevention and early detection.
Early detection through regular screening greatly increases the chances of successful treatment and survival.
While some risk factors cannot be changed, understanding them helps in making informed health decisions.
Persistent HPV infection is responsible for nearly all cases
Regular screening can prevent up to 80% of cases
Among women in developing countries
Cervical cancer primarily results from persistent infection with high-risk strains of human papillomavirus (HPV), a sexually transmitted virus. a weakened immune system, long-term oral contraceptive use, and multiple sexual partners. Nearly all cases link to HPV, but it often takes 8-10 years for precancerous cells to develop into cancer.
Early stages typically show no symptoms, making screening essential. Later signs include abnormal vaginal bleeding (between periods, after sex, or post-menopause), unusual discharge, pelvic pain, pain during intercourse, or unexplained weight loss.
Screening through V.I.A (Visual Inspection with Acetic Acid) is approved by the World Health Organization. Every married woman should undergo this test once every year. Regular screening can prevent over 90% of cases.
Diagnosis starts with V.I.A results, followed by colposcopy (magnified cervix exam) and biopsy. Staging uses imaging (CT, MRI, PET) and exams to assess spread to lymph nodes or beyond.
Early-stage (0-I) often uses surgery like cone biopsy or hysterectomy; advanced stages involve radiation, chemotherapy, targeted therapy, or immunotherapy. Fertility-sparing options exist for early cases if desired. Treatment considers stage, age, health, and fertility goals.
Stage I has over 90% five-year survival; overall rates improve with early detection. Recurrence monitoring post-treatment includes regular exams and imaging.
Is dedicated to empowering women through health awareness, early detection, and free screening programs. Together, we strive to build a healthier future for every woman.